Draxxin

Draxxin: A Comprehensive Overview of this Veterinary Antibiotic

Introduction:

Draxxin (tulathromycin) is a long-acting macrolide antibiotic frequently used in veterinary medicine, particularly for treating respiratory and other bacterial infections in cattle, swine, and other animals. Its unique extended-release formulation allows for a single injection to provide effective treatment for several days, offering convenience for both veterinarians and livestock owners. However, understanding its proper usage, potential side effects, and limitations is crucial for responsible and effective animal care. This article provides a detailed overview of Draxxin, explaining its mechanism of action, applications, administration, potential risks, and frequently asked questions.

Mechanism of Action:

Draxxin's effectiveness stems from its ability to bind to the 50S ribosomal subunit of bacterial cells. This binding inhibits protein synthesis, ultimately leading to bacterial death. Its broad-spectrum activity targets a wide range of gram-positive and gram-negative bacteria commonly implicated in bovine respiratory disease (BRD), swine respiratory disease (SRD), and other bacterial infections. Unlike some antibiotics that only affect actively growing bacteria (bacteriostatic), Draxxin is bacteriocidal, meaning it actively kills bacteria. This contributes to its efficacy in treating established infections.

Therapeutic Applications:

Draxxin is primarily prescribed for the treatment of bacterial respiratory infections in cattle and swine. In cattle, it's commonly used to treat BRD, which often presents with symptoms like coughing, nasal discharge, and reduced appetite. In swine, it's employed to combat SRD, characterized by similar respiratory symptoms as well as lethargy and decreased productivity. Beyond respiratory issues, Draxxin also finds application in treating other bacterial infections in various animal species, though its usage should always be guided by a veterinarian's diagnosis and prescription. For example, it might be used to treat bacterial infections associated with metritis (uterine infection) in cattle, or certain bacterial skin infections.

Administration and Dosage:

Draxxin is administered via intramuscular (IM) injection. The dosage varies depending on the animal species, weight, and the specific infection being treated. Incorrect dosage can lead to treatment failure or potential side effects, highlighting the importance of following the veterinarian's instructions precisely. The extended-release formulation allows for a single injection, eliminating the need for repeated administrations, contributing to improved compliance and reduced stress on the animal. The injection site should be carefully selected to minimize discomfort and potential complications.

Potential Side Effects and Contraindications:

While generally well-tolerated, Draxxin can cause some side effects in certain animals. These can include transient injection site reactions such as swelling or pain at the injection site. In rare cases, more serious reactions like hypersensitivity (allergic) reactions may occur. Therefore, a careful history should be taken to identify any known drug allergies before administration. Draxxin is contraindicated in animals with known hypersensitivity to macrolide antibiotics. It's crucial to inform the veterinarian about any pre-existing health conditions the animal may have before commencing treatment.

Precautions and Considerations:

The use of Draxxin, like any antibiotic, should be guided by a veterinarian's professional judgement. Improper use can contribute to the development of antibiotic resistance, reducing its effectiveness in the future. Furthermore, withdrawal times are crucial. This refers to the period after treatment during which the animal's products (meat, milk) cannot be sold for human consumption to ensure the absence of drug residues. Failure to adhere to withdrawal times can have significant economic and public health implications. Therefore, careful adherence to label instructions is paramount.

Drug Interactions:

Potential interactions with other drugs can occur. While not exhaustive, certain combinations should be approached with caution. For instance, concurrent use with other macrolide antibiotics or certain classes of drugs may lead to unforeseen side effects. A complete medication history should be provided to the veterinarian to ensure safe and effective use.

Summary:

Draxxin (tulathromycin) is a valuable tool in veterinary medicine for treating bacterial respiratory and other infections in livestock. Its long-acting formulation offers convenience and efficacy, but responsible usage is vital. Correct dosage, adherence to withdrawal times, awareness of potential side effects, and careful consideration of potential drug interactions are crucial for optimal results and preventing the development of antibiotic resistance. Always consult with a veterinarian for diagnosis, treatment, and monitoring of animals receiving Draxxin.

Frequently Asked Questions (FAQs):

1. How long does the effect of Draxxin last? Draxxin provides effective antibiotic concentrations for several days following a single injection, but the exact duration varies depending on the animal species and the specific infection.

2. Can I use Draxxin on all animals? No, Draxxin is primarily approved for use in cattle and swine, though its application in other species may be considered under veterinary supervision and with appropriate dosage adjustments.

3. What should I do if my animal experiences an adverse reaction to Draxxin? Contact your veterinarian immediately. Adverse reactions can range from mild injection site reactions to more serious systemic effects. Prompt veterinary attention is essential.

4. Is Draxxin safe for pregnant or lactating animals? The safety of Draxxin in pregnant and lactating animals should be carefully evaluated by a veterinarian. The potential benefits must be weighed against any potential risks to the mother or offspring.

5. What are the withdrawal times for Draxxin? Withdrawal times vary depending on the species and the intended use of the animal’s products (meat, milk). Always consult the product label or your veterinarian for the specific withdrawal times applicable to your situation. Failure to adhere to withdrawal times can result in drug residues in food products, posing a potential risk to human health.

Search Results:

Draxxin - patient leaflet, side effects, dosage Draxxin 100 mg/ml solution for injection for cattle, pigs and sheep. 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT. Marketing authorisation holder: Zoetis Belgium SA. Rue Laid Burniat 1. 1348 Louvain-la-Neuve. BELGIUM

Draxxin | Zoetis IE Draxxin is indicated for the treatment and prevention of Bovine Respiratory Disease associated with Mannheimia haemolytica, Pasturella multocida, Histophilus somni and Mycoplasma bovis. Draxxin is also indicated for the treatment of infectious bovine keratoconjunctivitis (IBK) associated wit Moraxella bovis. Dose rate: 1ml/40 kg. Withold period:

Draxxin® (tulathromycin injection) Injectable Solution DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass triamilide. Each mL of DRAXXIN contains 100 mg of tulathromycin as the free base in a 50% propylene glycol vehicle, monothioglycerol (5 mg/mL), with citric and hydrochloric acids added to adjust pH.

Zoetis Draxxin 100mg/ml Injection - Farmacy The presence of the disease in the herd should be established before preventative treatment. Draxxin should only be used if pigs are expected to develop the disease within 2-3 days. Sheep: Treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent Dichelobacter nodosus requiring systemic treatment.

Draxxin 100 mg/ml solution for injection POM - Hyperdrug The presence of the disease in the herd should be established before preventative treatment. Draxxin should only be used if pigs are expected to develop the disease within 2-3 days. Dosage and administration. Cattle. A single subcutaneous injection of 2.5 mg tulathromycin/kg body weight (equivalent to 1 ml/40 kg body weight).

Draxxin - Zoetis Draxxin is a core component of the Mhp Guardian program, a step-by-step approach that guides your organization through a herd status identification process and intervention assessment, along with a customized road map for either a control or elimination program, depending on your specific needs.

DRAXXIN - Zoetis DRAXXIN® (tulathromycin injection) Injectable Solution is an anti-infective approved for the treatment of bovine respiratory disease (BRD) caused by all four major bacterial pathogens, including Mycoplasma bovis and infectious bovine keratoconjunctivitis (pinkeye) in non-lactating beef and dairy cattle (including calves) and veal calves. DRAXXIN is also labeled for the treatment of foot rot.

Draxxin Injectable Solution for Animal Use - Drugs.com DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass triamilide. Each mL of DRAXXIN contains 100 mg of tulathromycin, 500 mg propylene glycol, 19.2 mg citric acid and 5 mg monothioglycerol.

Draxxin 100 mg/ml solution for injection for cattle & pigs Viewing Datasheet. Draxxin 100 mg/ml solution for injection for cattle, pigs & sheep. By Company

Draxxin - European Medicines Agency (EMA) Draxxin is an antibiotic medicine that contains the active substance tulathromycin. Draxxin is used to treat the following diseases if they are caused by bacteria that are sensitive to tulathromycin: bovine respiratory disease (BRD) in cattle caused by Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis;

Draxxin

Draxxin: A Comprehensive Overview of this Veterinary Antibiotic

Links:

Converter Tool

Conversion Result:

Formatted Text:

Search Results: